Unique ID issued by UMIN | UMIN000006437 |
---|---|
Receipt number | R000007641 |
Scientific Title | Loopamp Mycoplasma P detection kit Evaluation Study |
Date of disclosure of the study information | 2011/09/30 |
Last modified on | 2014/01/06 17:24:23 |
Loopamp Mycoplasma P detection kit
Evaluation Study
Myco-LAMP Evaluation Study
Loopamp Mycoplasma P detection kit
Evaluation Study
Myco-LAMP Evaluation Study
Japan |
Community acquired pneumonia (CAP) meeting the criteria of atypical pneumonia
Medicine in general | Pneumology | Infectious disease |
Others
NO
Evaluation of Loopamp Mycoplasma P diagnosis kit (Myco-LAMP) for diagnosis performance in CAP
patients
Others
Evaluation of Myco-LAMP for
diagnosis performance
Not applicable
Evaluate a clinical performance of Myco-LAMP for a pneumonia diagnosis in comparison of conventional IVDs and nucleic acid detection methodology.
1) Comparison of Myco-LAMP and serological test
Analysis of a positive agreement rate (sensitivity), a negative agreement rate (specificity) and an overall agreement rate between Myco-LAMP and serological test.
2) Comparison of Myco-LAMP and EIA (Immuno-Card)
Analysis of a positive agreement rate (sensitivity), a negative agreement rate (specificity) and an overall agreement rate between Myco-LAMP and EIA.
3) Comparison of Myco-LAMP and PCR
Analysis of a positive agreement rate (sensitivity), a negative agreement rate (specificity) and an overall agreement rate between Myco-LAMP and PCR
Observational
15 | years-old | <= |
Not applicable |
Male and Female
1) Regardless of inpatient or
outpatient.
2) Suspected CAP patient who
presents a new typical infiltrative shadow on CXR or CT image taken <48 hr before this study and who shows at least one other typical symptom described below
Coughing, or its exacerbation
Purulent sputum or its deteriorating.
Abnormal finding based on auscultation and percussion
Breathing difficulties and/ or Tachypnea
Fever with > 37 degree (axilla measurement)
CRP increasing (in according to an criteria of each study site)
Hypoxemia
3) Case which meets the criteria of 1) & 2) and which is suspected as atypical pneumoniae based on the policies to distinguish between atypical and bacterial pneumonia (Japanese Respiratory Society guidelines of community acquired pneumonia 2007)
4) Eligible patient who provides the informed consent signed by himself or his proxy.
1) Patient for whom a clinical follow-up and a clear final diagnosis are judged to be difficult.
2) Patient who is obviously suspected to be TB, lung suppuration, pneumonia complicating with lung cancer or HIV.
150
1st name | |
Middle name | |
Last name | Yoshifumi Imamura |
Nagasaki University Hospital
Second Department of Internal Medicine
1-7-1, Sakamoto, Nagasaki city, Nagasaki prefecture.
095-819-7273
yimamura@nagasaki-u.ac.jp
1st name | |
Middle name | |
Last name | Taiga Miyazaki |
Nagasaki evaluation organization for clinical interventions
office
Miyamura bld. 2F,11-13, Hirano-machi, Nagasaki city, Nagasaki prefecture.
095-842-5402
shinkin@peath.co.jp
Nagasaki evaluation organization for clinical interventions
Nagasaki evaluation organization for clinical interventions
Non profit foundation
Japan
Eiken Chemical Co., Ltd.
Eiken Chemical Co., Ltd.
NO
2011 | Year | 09 | Month | 30 | Day |
Unpublished
Completed
2011 | Year | 08 | Month | 24 | Day |
2011 | Year | 10 | Month | 01 | Day |
2013 | Year | 09 | Month | 20 | Day |
2013 | Year | 09 | Month | 30 | Day |
2013 | Year | 11 | Month | 30 | Day |
2014 | Year | 01 | Month | 31 | Day |
prospective study
2011 | Year | 09 | Month | 29 | Day |
2014 | Year | 01 | Month | 06 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007641